Eliot Forster, F-star CEO (Rachel Kiki for Endpoints News)
F-star gets down to the wire with $161M sale to Chinese buyer as national security concerns linger
With the clock ticking on F-star Therapeutics’ takeover by a Chinese buyer, the companies are still scrambling to remove a hold on the deal from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
